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1. Purpose
Cerebral inflammatory responses underlie the most prevalent neurological disorders, including
cancer, ischemia or neurodegeneration. In many cases, bioimaging methods are not able to
discriminate clearly between the pathology and the associated inflammatory response, making it
difficult to evaluate the effect of anti-inflammatory strategies.
On these grounds, the development of non-invasive methods to identify and characterize the
contribution of inflammatory components entails considerable therapeutic and diagnostic interest.
We report here, for the first time to our knowledge, a longitudinal MRS characterization of the cerebral
inflammatory component developed after the systemic administration of Lipopolysaccharide (LPS).
2. Material and Methods
Adult male mice C57BL/6 (n=6) received an i.p. injection of LPS from Escherichia Coli Serotype 0127:B8
(5mg/kg). MRS studies (Bruker Pharmascan 7T/16) of mouse brain were acquired from two cerebral
regions (Figure 1.) using PRESS sequences (TE/TR/NS:35ms/3000ms/128), before, one and three days
after LPS administration.
Fig. 1
Two regions selected for the acquisition of the PRESS sequences. Right: Representative spectra
obtained with LCModel for the two different regions selected, before (basal), one day and three
days after the LPS injection.
T1, T2, DWI, and MT images were also acquired from the same mice. H spectra were quantified with1
LCModel (20% Cranmer-Rao rejection limit) relative to the total-creatine (tCr) resonance. Parametric
maps were determined using in house software and quantified in cortex, thalamus and hippocampus.
Finally, mice were perfused transcardially 21 days after LPS injection. Brain sections were cut on
cryostat (20 µm thick) and immunostained with Mouse antiGFAP for histological evaluation.
3. Results
LPS administration induced significant variations in taurine (Tau) and total-choline (tCho) content,
especially one day after the injection, with lower effects in -acetylaspartate (NAA), macromoleculesN
and lipids (Figure 2).
Fig. 2
Fig.2: Mean (±SD) values of different metabolites measured with in-vivo PRESS spectroscopy; total
choline (tCho), taurine (Tau), N-acetylaspartate (NAA), lactate (Lac), total macromolecules and lipids
around 0.9 ppm (MM09+Lip09), in the two regions referred in Fig.1 (A) blue region, (B) violet
region. T-student significance is represented as *p<0.05. Note the significant decrease in Tau and
tCho one day after the injection; increasing tCho with respect to basal after threee days and the
gradual increase in Lac measured in some mice. Lower row: Mean (±SD) of metabolic ratios. Note
the increase of NAA/Cho and decrease in Cho/Lip09+MM09 one day after the injection, turning
over the effects three days after the injection.
Image analyses revealed significant variations in hippocampal MT and ADC and in the cortical ADC,
one day after the injection. On the third day, MT and ADC effects increased and a T2 increase was
detected in the hippocampus, disappearing the effects in cortex (Figure 3).
Fig. 3.
Fig.3 Mean (±SD) values of ADC antero-posterior (A-P), MT and T2 for the hippocampus (upper
panels) and ADC (A-P and left-right (L-R)) for the cortex (lower panels); before (blue), one (red) and
three (green) days after LPS administration. Paired t-test (basal with respect to one day and basal
with respect to three days) are represented as *p<0.05 and **p<0.01.
Immunostaining results confirmed astrogliosis exclusively in the hippocampus (Figure 4).
Fig. 4
Representative results of immunostaining with GFAP 21 one days after the sytemic LPS
administration. Note the astrogliosis exclusively in the hippocampus. Above left: Control mouse
(CA1, hippocampus). Above right: LPS infected mouse (CA1, hippocampus). Below left: LPS infected
mouse (cortical region). Below right: LPS infected mouse (thalamic region).
4. Conclusion
In-vivo spectroscopy reveals severe metabolic changes mainly affecting the osmolite Tau and the tCho
resonances. Together, these observations suggest that LPS inflammation involves augmented
phosphoplipid and osmolite turnover in both regions investigated. The spectroscopic changes appear
to be maximal 24h after LPS while the imaging changes peak at 72h in the hippocampus, suggesting
that metabolic changes detected by spectroscopy precede the final functional consequences
observed by imaging and histology.
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